Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 2
2017 1
2018 2
2019 1
2020 6
2021 2
2022 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Recurrence of Completely Resected NSCLC.
Masago K, Seto K, Fujita S, Sasaki E, Hosoda W, Kuroda H. Masago K, et al. Among authors: seto k. JTO Clin Res Rep. 2020 Jul 18;1(3):100076. doi: 10.1016/j.jtocrr.2020.100076. eCollection 2020 Sep. JTO Clin Res Rep. 2020. PMID: 34589953 Free PMC article.
The possibility of mutations of RAS signaling genes and/or TP53 in combination as a negative prognostic impact on pathological stage I non-small cell lung cancer.
Honda T, Seto K, Endo S, Takemoto A, Tanimoto K, Kobayashi M, Kitano M, Sakakibara R, Mitsumura T, Ishibashi H, Inazawa J, Tanaka T, Miyazaki Y, Okubo K. Honda T, et al. Among authors: seto k. Cancer Med. 2023 Oct;12(19):19406-19413. doi: 10.1002/cam4.6535. Epub 2023 Sep 15. Cancer Med. 2023. PMID: 37712717 Free PMC article.
Endovascular Treatment for Acute Ischemic Stroke After Video-Assisted Thoracoscopic Pulmonary Lobectomy in Patients With Lung Cancer: A Report of Four Cases and Literature Review.
Ueno H, Yamaoka H, Hirai S, Fujita K, Ishikawa M, Fujii S, Aizawa Y, Ishii Y, Yoshimura M, Yamada K, Yoshino Y, Kurata M, Seto K, Ishibashi H, Okubo K, Nemoto S, Sumita K. Ueno H, et al. Among authors: seto k. J Stroke Cerebrovasc Dis. 2022 Aug;31(8):106593. doi: 10.1016/j.jstrokecerebrovasdis.2022.106593. Epub 2022 Jun 10. J Stroke Cerebrovasc Dis. 2022. PMID: 35696736 Review.
Calculating the Tumor Nuclei Content for Comprehensive Cancer Panel Testing.
Mikubo M, Seto K, Kitamura A, Nakaguro M, Hattori Y, Maeda N, Miyazaki T, Watanabe K, Murakami H, Tsukamoto T, Yamada T, Fujita S, Masago K, Ramkissoon S, Ross JS, Elvin J, Yatabe Y. Mikubo M, et al. Among authors: seto k. J Thorac Oncol. 2020 Jan;15(1):130-137. doi: 10.1016/j.jtho.2019.09.081. Epub 2019 Oct 9. J Thorac Oncol. 2020. PMID: 31605798 Free article.
Sensitivity to dabrafenib and trametinib treatments in patients with non-small-cell cancer harboring BRAF compound mutations: A pooled analysis of BRAF p.V600E-positive advanced non-small-cell lung cancer.
Seto K, Shimizu J, Masago K, Araki M, Katayama R, Sagae Y, Fujita S, Horio Y, Sasaki E, Kuroda H, Okubo K, Okuno Y, Hida T. Seto K, et al. Cancer Genet. 2022 Aug;266-267:1-6. doi: 10.1016/j.cancergen.2022.05.001. Epub 2022 May 11. Cancer Genet. 2022. PMID: 35598548
Novel Resistance Mechanisms Including L1196Q, P1094H, and R1248_D1249 Insertion in Three Patients With NSCLC After ALK Tyrosine Kinase Inhibitor Treatment.
Furuta H, Araki M, Masago K, Sagae Y, Fujita S, Seto K, Shimizu J, Horio Y, Sasaki E, Hosoda W, Katayama R, Okuno Y, Hida T. Furuta H, et al. Among authors: seto k. J Thorac Oncol. 2021 Mar;16(3):477-482. doi: 10.1016/j.jtho.2020.09.023. Epub 2020 Nov 6. J Thorac Oncol. 2021. PMID: 33166721 Free article.
22 results